Particularly, it was shown that mutated NPM1-derived peptides are presented on the surface of AML and one of these peptides (CLAVEESL) is a neontigen that can be targeted on AML by mutant NPM1 T cell receptor gene transfer [68]. The gene discussed is NPM1; the disease is acute myeloid leukemia.